Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
Clinical trial NCT07226258 · RECRUITING
Trial details
- NCT number
- NCT07226258
- Sponsor
- Saol Therapeutics Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-11-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.